Molbio is an innovative point-of-care diagnostics enterprise focused on expanding access to accurate, rapid, and cost-effective healthcare technologies for the diagnosis of infectious and non-communicable diseases. Its portable, battery-operated “Truenat” platform enables molecular diagnosis using disease-specific test kits with results available within an hour. As of Mar 31, 25, the Truenat platform supports screening and diagnosis for over 30 diseases, including tuberculosis, COVID-19, Hepatitis B and C, human immunodeficiency virus, and human papillomavirus. In addition to molecular diagnostics, the Company offers devices for radiology, digital pathology, and breast health screening. Its products are supplied globally to public health programs, diagnostic laboratories, and private and public hospitals.
Price Band₹ |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹200.00 Cr (0.00 Shares) |
Offer For Sale₹0.00 (1.26 Cr Shares) |
Total Issue( Shares) |
Face Value₹0 per equity share |
| Particulars | Allocation |
|---|---|
| QIBs | Not more than 50% of Net Offer |
| Big HNIs (NII) | Not less than 10% of Net Offer |
| Small HNIs (NII) | Not less than 5% of Net Offer |
| Retail | Not less than 35% of Net Offer |
| Particulars | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Revenue | 1,020.42 | 836.56 | 332.46 |
| PAT | 138.58 | 83.54 | -3.45 |
| Net Worth | 952.95 | 807.94 | 706.04 |
| Borrowings | 123.16 | 174.58 | 108.44 |
| Assets | 1,461.56 | 1,221.06 | 1,034.21 |
| NAV (₹) | 84.51 | 71.70 | 62.66 |
| EPS (₹) | 12.87 | 9.05 | -0.06 |
The financial information presented is on a consolidated basis.
| KPI | VALUES |
|---|---|
| EBITDA | 24.97% |
| PAT | 13.48% |
| ROE | 16.20% |
| ROCE | 20.98% |
| Name | Shareholding |
|---|---|
| Exxora Trading LLP | 41.23% |
| Chandrasekhar Nair | 5.42% |
| Total | 46.65% |
| Name | Designation |
|---|---|
| Sriram Natarajan | CEO |
| Suhas Advant | CFO |
Name: Molbio Diagnostics Limited
Address: Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa 403 722, Goa, India
Number: +91 832 6724888
Email: investors@molbiodiagnostics.com
Website: www.molbiodiagnostics.com
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Molbio Diagnostics IPO is a Mainboard IPO having an issue size of Rs. ₹0.00 Crs. Molbio Diagnostics IPO is priced at ₹ - ₹ per share. The issue opens on 11 Feb 26 and closes on 11 Feb 26.
Molbio Diagnostics IPO opens on 11 Feb 26 and closes on 11 Feb 26.
The estimated Grey Market Premium of Molbio Diagnostics IPO is ₹0 per share (-).
The minimum lot size of Molbio Diagnostics IPO is 0 shares & the minimum application amount is Rs. 0.
The allotment date of Molbio Diagnostics IPO is 11 Feb 26.
The listing date of Molbio Diagnostics IPO is 11 Feb 26.
Molbio Diagnostics IPO is subscribed -.
Molbio Diagnostics IPO is priced at ₹ - ₹ per share.
Click the allotment link on Molbio Diagnostics IPO page of IPO360.